Description
The first SPH was convened as a response to the impossibility of observing Baveno IV recommendations emerging after the withdrawal of non-selective beta blockers from the slovak market.
Read more on event’s website.
Scientiffic committee
Tomas KOLLER MD, PhD
Martin JANICKO MD, PhD
Organizing committee
Svetlana ADAMCOVA-SELCANOVA MD